Hospitals start pilot testing RFID to curb drug diversion

May 17, 2004

M.D. Anderson Cancer Center in Houston is testing RFID on two medications, Neupogen (filgrastim, Amgen) and Procrit (epoetin alfa, Ortho Biotech).